From €2665EUR$2,975USD£2,271GBP
€3135EUR$3,500USD£2,672GBP
- Report
- November 2023
- 178 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- October 2023
- 90 Pages
United States
From €2665EUR$2,975USD£2,271GBP
€3135EUR$3,500USD£2,672GBP
- Report
- October 2023
- 89 Pages
Malaysia
From €2665EUR$2,975USD£2,271GBP
€3135EUR$3,500USD£2,672GBP
- Report
- October 2023
- 90 Pages
Israel
From €2665EUR$2,975USD£2,271GBP
€3135EUR$3,500USD£2,672GBP
- Report
- August 2023
- 76 Pages
Egypt
From €2665EUR$2,975USD£2,271GBP
€3135EUR$3,500USD£2,672GBP
- Report
- October 2021
- 78 Pages
United States
From €2665EUR$2,975USD£2,271GBP
€3135EUR$3,500USD£2,672GBP
- Report
- February 2024
- 96 Pages
North America
From €4255EUR$4,750USD£3,627GBP
- Report
- February 2024
- 115 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Drug Pipelines
- July 2022
- 60 Pages
Global
From €2015EUR$2,250USD£1,718GBP
- Report
- February 2024
- 110 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- February 2024
- 143 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- February 2024
- 120 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- February 2024
- 132 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- April 2023
- 115 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- September 2023
- 93 Pages
Global
From €3583EUR$4,000USD£3,054GBP
- Report
- January 2024
- 200 Pages
Global
From €3717EUR$4,150USD£3,169GBP
- Report
- August 2023
- 145 Pages
Global
From €2821EUR$3,150USD£2,405GBP
- Report
- June 2019
- 159 Pages
Global
From €3986EUR$4,450USD£3,398GBP
- Report
- April 2022
- 154 Pages
Africa, Middle East
From €1344EUR$1,500USD£1,145GBP

The Leadless Cardiac Pacemaker is a type of cardiovascular device used to treat bradycardia, a condition in which the heart beats too slowly. It is a small, self-contained device that is implanted directly into the heart, eliminating the need for a traditional pacemaker with leads. This type of pacemaker is designed to reduce the risk of infection and other complications associated with traditional pacemakers. It also offers improved patient comfort and convenience, as well as improved longevity.
Leadless Cardiac Pacemakers are becoming increasingly popular due to their advantages over traditional pacemakers. They are also becoming more widely available, with many medical device companies offering them. Some of the companies in the Leadless Cardiac Pacemaker market include Medtronic, Abbott, Biotronik, Boston Scientific, and St. Jude Medical. Show Less Read more